Francis Willard Sarena Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Francis Willard Sarena.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Francis Willard Sarena. Francis Willard Sarena is Exec Dir/Chief Legal Off/Secy in PDL BIOPHARMA, INC. ($PDLI) and VP/Gen Counsel/Secy in PDL BIOPHARMA, INC. ($PDLI) and Chief Strategy Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and EVP, Gen Counsel & Secretary in FIVE PRIME THERAPEUTICS INC ($FPRX) and EVP, Gen Counsel and Secretary in FIVE PRIME THERAPEUTICS INC ($FPRX) and SVP, Gen Counsel & Secretary in FIVE PRIME THERAPEUTICS INC ($FPRX).
Latest Insider Trading Transactions of Francis Willard Sarena
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 11.97 | 58,000 | 694,260 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 18.69 | 45,000 | 841,050 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 19.25 | 75,000 | 1,443,750 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 11.14 | 25,521 | 284,304 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 10.77 | 3,209 | 34,561 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 7.26 | 12,063 | 87,577 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 5.54 | 9,142 | 50,647 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | D | 8.49 | 4,747 | 40,302 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 795 | 30,210 | 0 | 795 to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | D | 38.00 | 169,468 | 6,439,784 | 0 | 169.5 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 66,000 | 0 | 169,468 | 103.5 K to 169.5 K (+63.79 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 14,174 | 0 | 103,468 | 117.6 K to 103.5 K (-12.05 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 2,460 | 0 | 117,642 | 120.1 K to 117.6 K (-2.05 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 1,440 | 0 | 120,102 | 121.5 K to 120.1 K (-1.18 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 795 | 0 | 795 | 0 to 795 |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Gift | G | 0.00 | 2,385 | 0 | 121,542 | 123.9 K to 121.5 K (-1.92 %) |
Mar 02 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 22.23 | 1,158 | 25,742 | 123,433 | 124.6 K to 123.4 K (-0.93 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 23.08 | 1,653 | 38,151 | 124,591 | 126.2 K to 124.6 K (-1.31 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 25.71 | 5,100 | 131,121 | 126,244 | 131.3 K to 126.2 K (-3.88 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 | |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 16.14 | 11,583 | 186,950 | 126,427 | 138 K to 126.4 K (-8.39 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 0.00 | 22,000 | 0 | 138,010 | 116 K to 138 K (+18.96 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 4.83 | 1,304 | 6,298 | 105,011 | 106.3 K to 105 K (-1.23 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 4.87 | 1,863 | 9,073 | 106,315 | 108.2 K to 106.3 K (-1.72 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 15,000 | 0 | 108,178 | 93.2 K to 108.2 K (+16.10 %) |
Feb 26 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 15,000 | 0 | 93,178 | 78.2 K to 93.2 K (+19.19 %) |
Feb 06 2020 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 5.13 | 4,070 | 20,879 | 78,178 | 82.2 K to 78.2 K (-4.95 %) |
Sep 04 2019 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 5.43 | 2,811 | 15,264 | 82,248 | 85.1 K to 82.2 K (-3.30 %) |
Jun 26 2019 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 0.00 | 44,000 | 0 | 44,000 | |
Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 11.97 | 58,000 | 694,260 | 58,000 | |
Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 11.95 | 1,194 | 14,268 | 82,955 | 84.1 K to 83 K (-1.42 %) |
Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 10,000 | 0 | 84,149 | 74.1 K to 84.1 K (+13.49 %) |
Feb 07 2019 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 11.43 | 2,996 | 34,244 | 74,149 | 77.1 K to 74.1 K (-3.88 %) |
Oct 02 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 13.92 | 954 | 13,280 | 77,145 | 78.1 K to 77.1 K (-1.22 %) |
Oct 02 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 1,923 | 0 | 78,099 | 76.2 K to 78.1 K (+2.52 %) |
Sep 05 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 14.00 | 2,810 | 39,340 | 76,177 | 79 K to 76.2 K (-3.56 %) |
Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 18.69 | 45,000 | 841,050 | 45,000 | |
Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 7,000 | 0 | 78,987 | 72 K to 79 K (+9.72 %) |
Sep 07 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 34.34 | 3,131 | 107,519 | 71,987 | 75.1 K to 72 K (-4.17 %) |
Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 44.77 | 19,784 | 885,730 | 75,118 | 94.9 K to 75.1 K (-20.85 %) |
Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 45.38 | 45,000 | 2,042,100 | 45,000 | |
Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 5,768 | 0 | 94,902 | 89.1 K to 94.9 K (+6.47 %) |
Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 10,310 | 0 | 89,134 | 78.8 K to 89.1 K (+13.08 %) |
Jan 18 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 5.54 | 3,636 | 20,143 | 9,142 | |
Jan 18 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 47.39 | 3,636 | 172,310 | 78,824 | 82.5 K to 78.8 K (-4.41 %) |
Jan 18 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 5.54 | 3,636 | 20,143 | 82,460 | 78.8 K to 82.5 K (+4.61 %) |
Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 48.60 | 2,442 | 118,681 | 78,824 | 81.3 K to 78.8 K (-3.00 %) |
Nov 30 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 5.54 | 1,710 | 9,473 | 12,778 | |
Nov 30 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 60.14 | 1,710 | 102,839 | 81,266 | 83 K to 81.3 K (-2.06 %) |
Nov 30 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 5.54 | 1,710 | 9,473 | 82,976 | 81.3 K to 83 K (+2.10 %) |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 5.54 | 10,264 | 56,863 | 14,488 | |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 6.89 | 10,925 | 75,273 | 0 | |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 6.89 | 13,465 | 92,774 | 10,925 | |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 60.48 | 21,189 | 1,281,511 | 81,266 | 102.5 K to 81.3 K (-20.68 %) |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 5.54 | 10,264 | 56,863 | 102,455 | 92.2 K to 102.5 K (+11.13 %) |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 6.89 | 10,925 | 75,273 | 92,191 | 81.3 K to 92.2 K (+13.44 %) |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 60.23 | 13,465 | 810,997 | 81,266 | 94.7 K to 81.3 K (-14.21 %) |
Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 6.89 | 13,465 | 92,774 | 94,731 | 81.3 K to 94.7 K (+16.57 %) |
Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 49.54 | 35,000 | 1,733,900 | 35,000 | |
Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 7,000 | 0 | 81,266 | 74.3 K to 81.3 K (+9.43 %) |
Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Payment of Exercise | F | 44.74 | 19,568 | 875,472 | 74,266 | 93.8 K to 74.3 K (-20.85 %) |
Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | A | 43.71 | 60,000 | 2,622,600 | 60,000 | |
Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Grant | A | 0.00 | 10,000 | 0 | 93,834 | 83.8 K to 93.8 K (+11.93 %) |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | M | 8.49 | 5,550 | 47,120 | 4,747 | |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | M | 8.49 | 3,524 | 29,919 | 10,297 | |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | M | 8.49 | 926 | 7,862 | 0 | |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Sell | S | 40.01 | 5,550 | 222,056 | 83,834 | 89.4 K to 83.8 K (-6.21 %) |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Buy | M | 8.49 | 5,550 | 47,120 | 89,384 | 83.8 K to 89.4 K (+6.62 %) |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Sell | S | 40.00 | 4,450 | 178,000 | 83,834 | 88.3 K to 83.8 K (-5.04 %) |
Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Buy | M | 8.49 | 4,450 | 37,781 | 88,284 | 83.8 K to 88.3 K (+5.31 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 8.49 | 1,513 | 12,845 | 926 | |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 5.54 | 7,768 | 43,035 | 24,752 | |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 7.26 | 7,449 | 54,080 | 12,063 | |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 10.77 | 3,791 | 40,829 | 3,209 | |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 11.14 | 9,479 | 105,596 | 25,521 | |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.00 | 1,513 | 52,955 | 83,570 | 85.1 K to 83.6 K (-1.78 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 8.49 | 1,513 | 12,845 | 85,083 | 83.6 K to 85.1 K (+1.81 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 34.73 | 7,768 | 269,783 | 83,570 | 91.3 K to 83.6 K (-8.50 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 5.54 | 7,768 | 43,035 | 91,338 | 83.6 K to 91.3 K (+9.30 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.11 | 7,449 | 261,534 | 83,570 | 91 K to 83.6 K (-8.18 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 7.26 | 7,449 | 54,080 | 91,019 | 83.6 K to 91 K (+8.91 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.31 | 3,791 | 133,860 | 83,570 | 87.4 K to 83.6 K (-4.34 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 10.77 | 3,791 | 40,829 | 87,361 | 83.6 K to 87.4 K (+4.54 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 36.13 | 2,584 | 93,360 | 83,570 | 86.2 K to 83.6 K (-3.00 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.55 | 6,895 | 245,117 | 86,154 | 93 K to 86.2 K (-7.41 %) |
Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 11.14 | 9,479 | 105,596 | 93,049 | 83.6 K to 93 K (+11.34 %) |
Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Grant | A | 0.00 | 75,000 | 0 | 83,570 | 8.6 K to 83.6 K (+875.15 %) |
Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | SVP, Gen Counsel & ... | Option Exercise | A | 19.25 | 75,000 | 1,443,750 | 75,000 | |
May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | SVP, Gen Counsel & ... | Grant | A | 0.00 | 6,110 | 0 | 8,570 | 2.5 K to 8.6 K (+248.37 %) |
Sep 17 2008 | PDLI | PDL BIOPHARMA, INC ... | Sarena Francis Willard | VP/Gen Counsel/Secy | Payment of Exercise | F | 10.84 | 536 | 5,810 | 5,756 | 6.3 K to 5.8 K (-8.52 %) |
Feb 01 2008 | PDLI | PDL BIOPHARMA, INC ... | Sarena Francis Willard | Exec Dir/Chief Lega ... | Grant | A | 0.00 | 2,000 | 0 | 6,292 | 4.3 K to 6.3 K (+46.60 %) |
Page: 1